Cyclosporin and Renal Injury

  • R. Maiorca
  • F. Scolari
  • S. Savoldi
  • S. Sandrini
  • P. Scaini
  • L. Cristinelli
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 252)


Ciclosporin (Cs) introduction as a new immunosuppressive drug has led to a significant improvement in graft and patient survival in organ transplantation (1–5) and has opened new perspectives in the treatment of autoimmune diseases and steroid-resistant nephrotic syndrome (6–8).


Acute Rejection Interstitial Fibrosis Renal Allograft Renal Transplant Patient Acute Tubular Necrosis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    The Canadian Multicentre Transplant Study Group, A randomized clinical trial of Cyclosporin in cadaveric renal transplantation, N. Engl. J. Med. 309:809 (1 983).Google Scholar
  2. 2.
    European Multicentre Trial Group, Cyclosporin in cadaveric renal transplantation: one year follow-up of a multicentre trial, Lancet 29:986 (1983).CrossRefGoogle Scholar
  3. 3.
    R. M. Merlon, D. J. G. White, S. Thiru, D. B. Evans, R. Y. Calne, Cyclosporine: five years experience in cadaveric renal transplantation, N. Engl. J. Med. 310:148 (1984).CrossRefGoogle Scholar
  4. 4.
    B. D. Myers, J. Ross, L. Newtov, J. Luetscher, M. Perlroth, Cyclosporine-associated chronic nephropathy, N. Engl. J. Med. 311:699 (1983).CrossRefGoogle Scholar
  5. 5.
    S. Iwatsuki, C. O. Esquivel, G. B. G. Klintmalm, R. D. Gordon, B. W. Shaw, T. E Starzl, Nephrotoxicity of Cyclosporine in liver transplantation, Transplant. Proc. 17, 4 (Suppl.1):191 (1985).Google Scholar
  6. 6.
    A. Van Rijthoven, B. Dijkmans, H. S. Goei The, J. Hermans, Z. Montnor-Beckers, P. Jacobs, Cyclosporin treatment for rheumatoid arthritis: a placebo controlled, double blind, multicentre study, Ann. Rheumatic Diseases 45:726 (1986).CrossRefGoogle Scholar
  7. 7.
    A. G. Palestine, R. B. Nussenblatt, C-C. Chan, Side effects of systemic Cyclosporine in patients not undergoing transplantation. Am. J. Med. 77:652 (1984).PubMedCrossRefGoogle Scholar
  8. 8.
    A. Tejani, K. Butt, H. Trachtman, M. Suthanthiran, C. J. Rosenthal, R. Khawar, Cyclosporine A induced remission of relapsing nephrotic syndrome in children. Kidney International. 33:729 (1988).PubMedCrossRefGoogle Scholar
  9. 9.
    A. W. Thomson, P. H. Whiting, I. D. Cameron, S. E. Lessels, J. G. Simpson, A toxicological study in rats receiving immunotherapeutic doses of Cyclosporin, Transplantation. 31:121 (1981).PubMedCrossRefGoogle Scholar
  10. 10.
    R. Y. Calne, K. Rolles, S. Thiru, P. Mc Master, G. N. Craddock, Cyclosporin A initially as the only Immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreas and 2 livers, Lancet. 2:1033 (1979).PubMedCrossRefGoogle Scholar
  11. 11.
    G. Klintmalm, S. O. Bohman, B. Sundelin, H. Wilczek, Interstitial fibrosis in renal allografts after 12 to 46 months of Cyclosporin treatment: beneficial effect of low doses in early post-transplantation period, Lancet. 27:950 (1984).CrossRefGoogle Scholar
  12. 12.
    M. J. Mihatsch, G. Thiel, H. P. Spichtin, M. Oberholzer, F. P. Brunner, F. Harder, V. Olivieri, R. Bremer, B. Ryffel, E. Stocklin, J. Torhorst, F. Gudat, H. U. Zollinger, R. Loertscher, Morphological findings in kidney transplants after treatment with Cyclosporine, Transplant. Proc. 15, 4 (suppl.1):2821 (1983).Google Scholar
  13. 13.
    B. A. Sullivan, L. J. Hak, W. F. Finn, Cyclosporine nephrotoxicity: studies in laboratory animals, Transplant. Proc. 17, 4 (suppl.1):145 (1985).Google Scholar
  14. 14.
    P. H. Whiting, A. W. Thomson, J. T. Blair, J. G. Simpson, Experimental Cyclosporin A nephrotoxicity, Br. J. Exp. Path. 63:88 (1982).Google Scholar
  15. 15.
    M. J. Mihatsch, B. Ryffel, M. Hermie, F. P. Brunner, G. Thiel, Morphology of Cyclosporine nephrotoxicity in the rat, Clin. Neph. 25 (suppl.1):2 (1986).Google Scholar
  16. 16.
    B. M. Murray, M. S. Palier, T. F. Ferris, Effect of Cyclosporine administration on renal hemodynamics in conscious rats, Kidney Int. 28:767 (1985).PubMedCrossRefGoogle Scholar
  17. 17.
    E. J. G. Barros, M. A. Boim, H. Ajzen, O. L. Ramos, N. Schor, Glomerular Hemodynamics and hormonal participation on Cyclosporine nephrotoxicity, Kidney Inter. 32:19 (1987).CrossRefGoogle Scholar
  18. 18.
    M. Sabbatini, C. Esposito, F. Uccello, A. Dal Canton, V. Andreucci, Effects of Cyclosporine on glomerular dynamics: micropuncture study in the rat, in Abstrats of The Second International Congress on Cyclosporine. Washington 1987:117 (1987).Google Scholar
  19. 19.
    J. English, A. Evan, C. D. Houghton, W. M. Bennett, Cyclosporine-induced acute renal disfunction in the rat. Transplantation. 44,1:135 (1987).Google Scholar
  20. 20.
    G. Conte, P. Napodano, L. De Nicola, G. Gigliotti, C. Libetta, P. Imperatofe, A. Testa, V. Sepe, A. Dal Canton, V. Andreucci, Dopamine counteracts the acute renal effects of Cyclosporine in normal subjects in Abstracts of The Second International Congress on Cyclosporine. Washington 1987:121 (1987).Google Scholar
  21. 21.
    B. D. Myers, R. Sybley, L Newton, S. J. Tomlanovich, C. Boshkos, E. Stinson, J. A. Luetscher, D. J. Whitney, D. Krasny, N. S. Coplon, M. G. Perlroth, The long-term course of Cyclosporine-associated chronic nephropathy. Kidney Int. 33:590 (1988).PubMedCrossRefGoogle Scholar
  22. 22.
    Curtis J. J., Luke R. G., Dubovsky E., Diethelm A. G., Whelchel G. D., Jones P.: Cyclosporin in therapeutic doses increases renal allograft vascular resistance. Lancet 1986, 30:477CrossRefGoogle Scholar
  23. 23.
    C. R. Baxter, G. C. Duggin, B. M. Hall, J. S. Horvath, D. J. Tiller, Stimulation of renin release from rat renal cortical slices by Cyclosporin A, Res. Commun. Chem. Pathol. Pharmacol. 43, 3:417 (1984).PubMedGoogle Scholar
  24. 24.
    N. Perico, A. Benigni, E. Bosco, M. Rossini, S. Orisio, F. Ghilardi, A. Piccinelli, G. Remuzzi, Acute Cyclosporine A Nephrotoxicity in rats: which role for renin-angiotensin system and glomerular prostaglandins?, Clin. Nephrol. 25 (suppl.1):83 (1986).Google Scholar
  25. 25.
    J. P. Bantle, K. A. Nath, D. E. Sutherland, J. S. Najarian, T. F. Ferris, Effects of Cyclosporine on the renin angiotensin aldosterone system and potassium excretion in renal transplant recipients. Arch. Int. Med. 145:505 (1985).CrossRefGoogle Scholar
  26. 26.
    T. P. Fan, G. P. Lewis, Mechanism of Cyclosporine A-induced inhibition of prostacyclin synthesis by macrophases. Prostaglandins. 30: 735 (1985).PubMedCrossRefGoogle Scholar
  27. 27.
    G. Neild, G. Rocchi, L. Imberti, Z. Brown, G. Remuzzi, D. G. Williams, Effect of Cyclosporine on prostacyclin synthesis by vascular tissue in rabbits, Transplant. Proc. 15 (suppl.1):2398 (1983).Google Scholar
  28. 28.
    A. Kawaguchi, M. N. Goldman, R. Shapiro, M. L. Foegh, P. W. Ramwell, R. R. Lower, Increase in urinary thromboxane B2 in rats caused by Cyclosporine, Transplantation. 40:214 (1985).PubMedCrossRefGoogle Scholar
  29. 29.
    M. S. Palier, Effects of the prostaglandin El analog misoprostol on Cyclosporine nephrotoxicity, in Abstracts of The Second International Congress on Cyclosporine. Washington 1987:32 (1987).Google Scholar
  30. 30.
    D. Adu, C. J. Lote, J. Michael, J. H. Turney, P. McMaster, Does Cyclosporine inhibit renal prostaglandin synthesis?, Proc. EDTA-ERA. 21:969 (1984).Google Scholar
  31. 31.
    T. Kho, K. Leunissen, J. Van Hooff, Cyclosporine and urinary prostaglandins, in Abstracts of The Second Internatinal Congrss on Cyclosporine. Washington 1987:36 (1987).Google Scholar
  32. 32.
    D. Jorkasky, P. Audet, S. Williams, R. Grossman, M. Conrad, Cyclosporine-induced nephrotixicity: role of prostaglandins, Transplant. Proc. 19, 1:1742 (1987).PubMedGoogle Scholar
  33. 33.
    P. M. Colombani, A. Robb, A. D. Hess, Cyclosporine A binding to calmodulin: a possible site of action on T lymphocytes, Science. 228:337 (1985).PubMedCrossRefGoogle Scholar
  34. 34.
    K. A. Duggan, G. J. Macdonald, J. A. Charlesworth, B. A. Pussel, Verapamil prevents post transplant oliguric renal failure, Clin. Nephrol. 24, 6:289 (1985).Google Scholar
  35. 35.
    H. Dieperink, H. Starklint, P.P. Leyssac, Nephrotoxicity of Cyclosporine-an animal model: study of the Nephrotoxic effect of Cyclosporine on overal renal and tubular function in conscious rats, Transplant. Proc. 15 (suppl.1):520 (1983).Google Scholar
  36. 36.
    J. S. Najarian, D. S. Fryd, M. Strand, D. Canafax, N. L. Ascher, W. D. Payne, R. L. Simmons, D. E. R. Sutherland, A single institution, randomized, prospective trial of Cyclosporine versus Azathioprine-Antilymphocyte globulin for immunosuppression in renal allograft recipients, Ann. Surgery. 201, 2:142 (1985).CrossRefGoogle Scholar
  37. 37.
    B. D. Kahan Meeting report: the first international congress on Cyclosporine: Houston, Texas. Dial. Transplant. 12:620 (1983).Google Scholar
  38. 38.
    S. M. Flechner, C. T. Van Buren, R. Kerman, B. D. Kahan, The effect of conversion from Cyclosporine to Azathioprine immunosuppression for intractable nephrotoxicity. Transplant. Proc. 15 (suppl.1):653 (1983).Google Scholar
  39. 39.
    G. Thil, M. Mihatsch, J. Landmann, M. Hermie, F. P. Brunner, F. Harder, Is Cyclosporine A-induced nephrotoxicity in recipients of renal allografts progressive?. Transplant. Proc. 17,4 (suppl.1):169 (1985).Google Scholar
  40. 40.
    E. Irschik, H. Tilg, D. Niederwieser, G. Gasti, C. Huber, R. Margreiter, Cyclosporin blood levels do correlate with clinical complications, Lancet. September 22:692 (1984).Google Scholar
  41. 41.
    R. Pichlmayr, K. Wonigeit, B. Ringe, T. Block, R. Raab, B. Heigel, P. Neuhaus, Rejection and nephrotoxicity. Diagnostic problems with Cyclosporine in renal transplantation, Proc. EDTA-ERA, 21:947 (1984).Google Scholar
  42. 42.
    G. C. Yee, M. S. Kennedy, H. J. Deeg, T. M. Leonard, E. D. Thomas, R. Storb, Cyclosporine-associated renal dysfunction in marrow transplant recipients, Transplant. Proc. 17, 4 (suppl.1): 196 (1985).Google Scholar
  43. 43.
    G. Klintmalm, J. Sawe, O. Ringden, C. von Bahr, A. Magnussen, Cyclosporine plasma levels in renal transplant patients. Transplantation. 39, 2:132 (1985).PubMedCrossRefGoogle Scholar
  44. 44.
    S. Drakopoulos, D. J. G. White, R. M. Merrion, S. Winter, R. Y. Calne, An assessment of the clinical value of monitoring Cyclosporine plasma levels, Transplant. Proc. 17:1258 (1985).Google Scholar
  45. 45.
    P. A. Keown, C. R. Stiller, A. C. Wallace, F. N. McKenzie, W. Wall, Cyclosporine nephrotoxicity: exploration of the risk factors and prognosis of the renal injury, Transplant. Proc. 17, 4 (suppl.1):247 (1985).Google Scholar
  46. 46.
    D. W. Holt, J. T. Marsden, A. Johnston, M. Bewick, D. H. Taube, Blood Cyclosporin concentrations and renal allograft dysfunction, Br. Med. J. 293:1057 (1986).CrossRefGoogle Scholar
  47. 47.
    B. D. Kahan, C. T. Van Buren, C. A. Wideman, D. A. Cooley, O. H. Frazier, Nephrotoxicity of Cyclosporine, N. Engl. J. Med. 312, 1:48 (1985).Google Scholar
  48. 48.
    R. Maiorca, L. Cristinelli, F. Scolari, S. Sandrini, S. Savoldi, G. Brunori, E. Prati, L. Lojacono, D. Salerni, G. Tonini, Cyclosporine toxicity can be minimized by careful monitoring of blood levels, Transplant. Proc. 17 (suppl.2):54 (1985).Google Scholar
  49. 49.
    S. Savoldi, B. D. Kahan, Relationship of Cyclosporine pharmacokinetic parameters to clinical events in human renal transplantation, Transplant. Proc. 18 (suppl.5):120 (1986).Google Scholar
  50. 50.
    C. W. B. Jensen, S. M. Flechner, C. T. Van Buren, O. H. Frazier, D. A. Cooley, M. I. Lorber, B. D. Kahan, Exacerbation of Cyclosporine toxicity by concomitant administration of erythromycin. Transplantation. 43:263 (1987).PubMedCrossRefGoogle Scholar
  51. 51.
    R. M. Ferguson, D. E. R. Sutherland, R. L. Simmons, G. S. Najarian, Ketoconazole, Cyclosporin metabolism and renal transplantation. Lancet. 2: 882 (1982).PubMedCrossRefGoogle Scholar
  52. 52.
    G. C. Yee, M. S. Kennedy, R. Storb, E. D. Thomas, Effect of hepatic dysfunction on oral Cyclosporine pharmacokinetics in marrow transplant patients. Blood. 64:1377 (1984).Google Scholar
  53. 53.
    L. D. Bowers, D. M. Canafax, J. Singh, R. Seifedlin, R. L. Simmons, J. S. Najarian, Studies of Cyclosporine blood levels: analysis, clinical utility, pharmacokinetics, metabolites, and chronopharmacology. Transplant. Proc. 18, (suppl.5):137 (1986).PubMedGoogle Scholar
  54. 54.
    B. M. Hall, D. J. Tiller, G. G. Duggin, J. S. Horvath, A. Farnsworth, J. May, J. R. Johnson, A. G. R. Sheil, Post-transplant acute renal failure in cadaver renal recipients treated with Cyclosporine, Kidney Int. 28: 178 (1985).PubMedCrossRefGoogle Scholar
  55. 55.
    K. Wonigheit, P. F. Hoyer, G. Schumann, B. Ringe, A. Frei, R. Picklmayr, Experiences with a blood level-adjusted Cyclosporine regimen in kidney and liver allograft recipients, Trasplant. Proc. 18 (suppl.5):181 (1986).Google Scholar
  56. 56.
    B. D. Kahan, Individualization of Cyclosporine therapy using pharmacokinetic andpharmacodynamic parameters. Transplantation. 40, 5:457 (1985).PubMedCrossRefGoogle Scholar
  57. 57.
    M. J. Mihatsch, G. Thiel, V. Basler, B. Ryffel, J. Landman, J. von Overbeck, H. U. Zollinger, Morphological patterns in Cyclosporine-treated renal transplant recipients. Transplant. Proc., 17, 4 (suppl.1):101 (1985).PubMedGoogle Scholar
  58. 58.
    B. D. Kahan, Clinical summation. An algorithm for the management of patients with Cyclosporine-induced renal dysfunction. Transplant. Proc. 17, 4 (suppl.1):303 (1985).PubMedGoogle Scholar
  59. 59.
    G. Klintmalm, O. Ringden, C. G. Groth, Clinical and laboratory signs in nephrotoxicity and rejection in Cyclosporine-treated renal allograft recipients, Transplant. Proc. 15, 4 (suppl.1):2815 (1983).Google Scholar
  60. 60.
    D. Taube, G. Neild, P. Hobby. D. Holt, K. Welsh, J. S. Cameron, A comparison of the clinical, histopathologic, cytologic, and biochemical features of renal transplant rejection, Cyclosporine A nephrotoxicity, and stable renal function. Transplant. Proc., 17, 4 (suppl.1):179 (1985).PubMedGoogle Scholar
  61. 61.
    P. Hayry, E. von Willebrand, Transplant aspiration cytology. Transplantation. 38:7 (1984).PubMedCrossRefGoogle Scholar
  62. 62.
    E. von Willebrand, P. Hayry, Cyclosporin-A deposits in renal allografts. Lancet. 2:189 (1983).CrossRefGoogle Scholar
  63. 63.
    P. Scaini, S. Savoldi, M. Favret, E. Prati, A. Manganoni, G. Setti, L. Cristinelli, F. Scolari, R. Maiorca, E’ evitabile la nefrotossicita acuta da Ciclosporina, Nefrologia, Dialisi, Trapianto, Wichtig Editore, Milano, ltaly:272 (1984).Google Scholar
  64. 64.
    P. Scaini, R. Tardanico, M. Favret, F. Scolari, S Savoldi, G. C. Cancarini, E. Prati, S. Sandrini, G. Brunori, L. Cristinelli, Are Cyclosporin A deposits in renal allografts of clinical significance?, Proc. EDTA-ERA, 22:546 (1985).Google Scholar
  65. 65.
    R. K. Sibley, J. Rynasiewicz, R. M. Ferguson, D. Fryd, D. E. R. Sutherland, R. L. Simmons, J. S. Najarian, Morphology of Cyclosporine nephrotoxicity and acute rejection in patients immunosuppressed with Cyclosporine and prednisone, Surgery. 94:225 (1983).PubMedGoogle Scholar
  66. 66.
    G. H. Neild, D. H. Taube, R. B. Hatley, L Bignardi, J. S. Cameron, D. G. Williams, C. S. Ogg, C. J. Rudge, Morphological differentiation between rejection and Cyclosporin nephrotoxicity in renal allografts, J. Clin. Pathol. 39: 152 (1986).CrossRefGoogle Scholar
  67. 67.
    A. Farnsworth, B. M. Hall, A. B. P. Ng, G. G. Duggin, J. S. Horvath, A. G. R. Sheil, D.J. Tiller, Renal biopsy morphology in renal transplantation, Am. J. Surg. Pathol. 8: 243 (1984).PubMedCrossRefGoogle Scholar
  68. 68.
    B. C. Konf, LC. Racuse, A. Whelton, K. Solez, Acute renal failure produced by combining Cyclosporine and brief renal ischemia in the Munich Wistar rat., Clin. Nephrol. 25(suppl.1):171 (1986).Google Scholar
  69. 69.
    European multicentre trial. Cyclosporin A as sole immunosuppressive agent in recipients of kidney allografts from cadaver donors. Lancet. 2:57 (1982).Google Scholar
  70. 70.
    S. Schuier, D. Thomas, R. Hetzer, Cyclosporine A-related nephrotoxicity after cardiac transplantation: the role of plasma renin activuty. Transplant. Proc. 19:3998 (1987).Google Scholar
  71. 71.
    B. D. Myers, Cyclosporine nephrotoxicity, Kidney Int. 30:964 (1986).PubMedCrossRefGoogle Scholar
  72. 72.
    A. G. Palestine, H. A. Austin III, J. E. Balow, T. T. Antonovych, S. G. Sabnis, H. G. Preuss, R. B. Nussenblatt, Renal histopathologic alterations in patients treated with Cyclosporine for uveitis, N. Engl. J. Med. 314,20: 1293 (1986).Google Scholar
  73. 73.
    K. Svenson, S-O. Bohman, R. Hallgren, Renal interstitial fibrosis and vascular changes. Arch. Intern. Med. 146: 2007 (1986).PubMedCrossRefGoogle Scholar
  74. 74.
    J. R. Chapman, D. Griffiths, N. G. L. Harding, P. J. Morris, Reversibility of Cyclosporin nephrotoxicity after three months’ treatment, Lancet. 1:128 (1985).PubMedCrossRefGoogle Scholar
  75. 75.
    B. von Graffenried, W. B. Harrison, Ciclosporin in autoimmune diseases. Side effects (with emphasis on renal dysfunction) and recommendations for use, in “Ciclosporin in autoimmne diseases”, R. Schindler ed., Springer-Verlag, Berlin (1985).Google Scholar
  76. 76.
    F. Scolari, S. Sandrini, S. Savoldi, L. Cristinelli, B. Brunori, E. Prati, G. Sacchi, R. Tardanico, G. C. Cancarini, R. Maiorca, Is Cyclosporine-induced chronic nephrotoxicity inevitable?. Transplant. Proc. 19:1745 (1987).PubMedGoogle Scholar
  77. 77.
    S. Thiru, E. R. Mäher, D. V. Hamilton, D. B. Evans, R. Y. Calne, Tubular changes in renal transplant recipients on Cyclosporine, Transpl. Proc. 15, 4 (suppl.1): 2846 (1983).Google Scholar
  78. 78.
    B. G. Sommer, J. T. Innes, R. M. Whitehurst, H. M. Sharma, R. M. Ferguson, Cyclosporine-associated renal arteriopathy resulting in loss of allograft function, Am. J. Surg. 149:756 (1985).PubMedCrossRefGoogle Scholar
  79. 79.
    C. Leithner, H. Sinzinger, E. Pohanka, M. Schwarz, G. Kretschmer, G. Syre, Recurrence of haemolytic uraemic syndrome triggered by Cyclosporin A after renal transplantation. Lancet. 1:1470 (1982).PubMedCrossRefGoogle Scholar
  80. 80.
    H. Shulman, G. Striker, H. J. Deeg, M. Kennedy, R. Storb, E. D. Thomas, Nephrotoxicity of Cyclosporin A after allogeneic marrow transplantation, N. Eng. J. Med. 305:1392 (1981).CrossRefGoogle Scholar
  81. 81.
    G. H. Neild, R. Reuben, R. B. Hartley, J. S. Cameron, Glomerular thrombi in renal allografts associated with Cyclosporin treatment, J. Clin. Pathol., 38: 253 (1985).PubMedCrossRefGoogle Scholar
  82. 82.
    S. Savoldi, F. Scolari, S. Sandrini, P. Scaini, G. Sacchi, R. Tardanico, C. Camerini, B. Salerni, G. Tonini, U. De Nobili, R. Maiorca, Ciclosporine chronic nephrotoxicity: hystological follow up at 6th and 18th month after renal transplantation, Transpl. Proc. (in press) (1988).Google Scholar
  83. 83.
    J. Goldstein, Y. Thoua, F. Wellens, J. L. Leerere, J. L. Vanherweghem, P. Vereerstraeten, G. Primo, C. Touissant, Cyclosporine nephropathy after heart and heart-lung transplantation, Proc. EDTA-ERA. 21:973 (1984).Google Scholar

Copyright information

© Plenum Press, New York 1989

Authors and Affiliations

  • R. Maiorca
    • 1
  • F. Scolari
    • 1
  • S. Savoldi
    • 1
  • S. Sandrini
    • 1
  • P. Scaini
    • 1
  • L. Cristinelli
    • 1
  1. 1.Institute of NephrologyUniversity and Spedali CiviliBresciaItaly

Personalised recommendations